Escolar Documentos
Profissional Documentos
Cultura Documentos
Thyroid Disorders
Therapeutics I
PHCL 416
Ahmed A AlAmer
PharmD
Email: Ahmedadel.pharmd@gmail.com
Hypothyroidism
1
09/01/35
M.W., a 70-kg, 23-year-old voice student, thinks that her neck has become fatter
over the past 3 to 4 months. She has gained 10 kg, feels mentally sluggish, tires easily,
and finds that she can no longer hit high notes.
Physical examination reveals puffy facies, yellowish skin, delayed DTRs, and a firm,
enlarged thyroid gland.
Laboratory data include FT4, 0.6 ng/dL (normal, 0.7 1.9); TSH, 60 units/mL
(normal, 0.54.7); and TPO antibodies, 136 IU/L (normal,<1).
2
09/01/35
Assess M.W.s thyroid status based on her clinical and laboratory findings.
3
09/01/35
Objective ?
reveals puffy facies, yellowish skin, delayed DTRs, and a firm, enlarged thyroid gland.
4
09/01/35
Goal of therapy ?
Therapy Goals for Both Hyperthyroid and Hypothyroid Disorders
5
09/01/35
Hyperthyroidism
6
09/01/35
She has a history of deep venous thrombosis treated with warfarin (Coumadin) 5
mg/day; her last prothrombin time (PT) was 18 seconds (normal, 10.512.1), and
an international normalized ratio (INR) was 1.8 (normal, 1; therapeutic, 23). She
has angina, treated withNTG0.4 mg, and CHF, treated with digoxin (Lanoxin)
0.25 mg/day.
Physical examination
reveals a thin, flushed, hyperkinetic, nervous woman.
Blood pressure (BP) is 180/90 mmHg; pulse is 130 beats/minute, irregularly irregular;
respiratory rate is 30 breaths/min; and temperature is 37.5C.
Other pertinent findings include a lid lag with stare, proptosis with tearing, a
diffusely enlarged thyroid gland without nodules, a bruit in the left lobe of the
thyroid, positive jugular venous distention (JVD), bibasilar rales, warm moist skin
with multiple bruises, new-onset atrial fibrillation (AF), slight diarrhea,
hepatomegaly, acropachy, 2+ pitting edema, a fine tremor, proximal muscle
weakness, and irregular scant menses
7
09/01/35
Laboratory data
FT4, 2.9 ng/dL (normal, 0.71.9); TSH,<0.5 units/mL (normal, 0.54.7); RAIU at 24
hours, 80% (normal, 5%35%); PT, 40 seconds (normal, 10.512.1); INR, 4.8
(normal, 1; therapeutic, 23); TPO, 200 IU/mL (normal,<1); alkaline phosphatase,
200 units/L (normal, 41133); total bilirubin, 1.1 mg/dL (normal, 0.11.2); AST, 60
units/L (normal, 726); and alanine aminotransferase (ALT), 55 units/L (normal,
323).
A scan shows a diffusely enlarged gland, three to four times normal size.
Assess M.W.s thyroid status based on her clinical and laboratory findings. ?
8
09/01/35
include chest pain that is unrelieved by NTG, increasing SOB with exercise, nervousness,
palpitations, muscle weakness, weight loss despite an increased appetite, and epistaxis;
she also bruises easily.
Blood pressure (BP) is 180/90 mmHg; pulse is 130 beats/minute, irregularly irregular;
respiratory rate is 30 breaths/min
a lid lag with stare, proptosis with tearing, a diffusely enlarged thyroid gland without
nodules, a bruit in the left lobe of the thyroid, positive jugular venous distention (JVD),
bibasilar rales, warm moist skin with multiple bruises, new-onset atrial fibrillation (AF),
slight diarrhea, hepatomegaly, acropachy, 2+ pitting edema, a fine tremor, proximal
muscle weakness, and irregular scant menses
FT4, 2.9 ng/dL (normal, 0.71.9); TSH,<0.5 units/mL (normal, 0.54.7); RAIU at 24
hours, 80% (normal, 5%35%); PT, 40 seconds (normal, 10.512.1); INR, 4.8
9
09/01/35
Classification
10
09/01/35
Classification
Pituitary adenomas:
Classification
Toxic adenoma
11
09/01/35
Classification
Classification
Painful subacute thyroiditis: Self-limiting thyroiditis caused by viral invasion of the
thyroid parenchyma, resulting in release of stored hormone
Drug induced (e.g., excessive thyroid hormone use, amiodarone)
12
09/01/35
Goal of therapy ?
Therapy Goals for Both Hyperthyroid and Hypothyroid Disorders
References
I. Koda Kimble , applied therapeutics
II. Pharmacotherapy Bedside Guide Christopher P. Martin,
Robert L. Talbert
III. Updates in Therapeutics: The Pharmacotherapy
Preparatory Review
VI. American Association of Clinical Endocrinologists: AACE
13